1. Liu, Junmei, Zhang, Ranran, Su, Tong, Han, Bo, Chen, Weiwen. 2023. Targeting PHB1 to inhibit castration-resistant prostate cancer progression in vitro and in vivo. In Journal of experimental & clinical cancer research : CR, 42, 128. doi:10.1186/s13046-023-02695-0. https://pubmed.ncbi.nlm.nih.gov/37210546/
2. Fan, Wei, Cao, DuoYao, Yang, Bing, Yang, Heping, Lu, Shelly C. 2023. Hepatic prohibitin 1 and methionine adenosyltransferase α1 defend against primary and secondary liver cancer metastasis. In Journal of hepatology, 80, 443-453. doi:10.1016/j.jhep.2023.11.022. https://pubmed.ncbi.nlm.nih.gov/38086446/
3. Wang, Heran, Zhou, Yujuan, Oyang, Linda, Li, Guiyuan, Liao, Qianjin. 2019. LPLUNC1 stabilises PHB1 by counteracting TRIM21-mediated ubiquitination to inhibit NF-κB activity in nasopharyngeal carcinoma. In Oncogene, 38, 5062-5075. doi:10.1038/s41388-019-0778-6. https://pubmed.ncbi.nlm.nih.gov/30886235/
4. Rosoff, Daniel B, Mavromatis, Lucas A, Bell, Andrew S, Horvath, Steve, Lohoff, Falk W. 2023. Multivariate genome-wide analysis of aging-related traits identifies novel loci and new drug targets for healthy aging. In Nature aging, 3, 1020-1035. doi:10.1038/s43587-023-00455-5. https://pubmed.ncbi.nlm.nih.gov/37550455/
5. Li, L, Guo, J-D, Wang, H-D, Yuan, Y-L, Hou, S-X. 2014. Prohibitin 1 gene delivery promotes functional recovery in rats with spinal cord injury. In Neuroscience, 286, 27-36. doi:10.1016/j.neuroscience.2014.11.037. https://pubmed.ncbi.nlm.nih.gov/25463519/
智鼠故事 
